Commentary on “Comparison of Survival Outcomes in Transarterial Ethanol Ablation and Liver Resection for Solitary Hepatocellular Carcinoma ≤ 5 cm in Patients Stratified by Liver Function”-Reference-Cited by-同舟云学术

Commentary on “Comparison of Survival Outcomes in Transarterial Ethanol Ablation and Liver Resection for Solitary Hepatocellular Carcinoma ≤ 5 cm in Patients Stratified by Liver Function”

Published:2022-01-19 Issue:3 Volume:45 Page:328-329
ISSN:0174-1551
Container-title:CardioVascular and Interventional Radiology
language:en
Short-container-title:Cardiovasc Intervent Radiol

Author:

Zhao Ken^ORCID,Sofocleous Constantinos T.,Yarmohammadi Hooman

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Link

https://link.springer.com/content/pdf/10.1007/s00270-021-03006-w.pdf

Reference8 articles.

1. Yu SCH, Hui JWY, Chong CCN, et al. Comparison of survival outcomes in transarterial ethanol ablation and liver resection for solitary hepatocellular carcinoma ≤ 5 cm in patients stratified by liver function. Cardiovasc Interv Radiol 2021;1–3

2. Luo W, Zhang Y, He G, et al. Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis. World J Surg Oncol. 2017;15(1):126.

3. Yu SC, Chan CT. Transarterial ethanol ablation of cirrhotic liver with lipiodol-ethanol mixture: safety and efficacy study in rats. Invest Radiol. 2006;41(8):609–17.

4. Yu SC, Hui EP, Wong J, et al. Transarterial ethanol ablation of hepatocellular carcinoma with lipiodol ethanol mixture: phase II study. J Vasc Interv Radiol. 2008;19(1):95–103.

5. Yu SC, Hui JW, Hui EP, et al. Unresectable hepatocellular carcinoma: randomized controlled trial of transarterial ethanol ablation versus transcatheter arterial chemoembolization. Radiology. 2014;270(2):607–20.